Novartis Recalls Excedrin, Gas-X and Other Popular Brands (Bloomberg Businessweek)

With stray tablets from other products appearing in the over-the-counter medicines, along with broken tablets, Novartis conducted a voluntary recall that could cost the company as much as $750 million.



View the Original article

Swiss Re Names Michel Lies CEO (Bloomberg Businessweek)

-- Related Coverage EU Demand for Road Map to Climate Treaty Complicates Talks (Bloomberg Businessweek) (11/28/11) Supreme Court to Decide Whether Lawsuits Require Harm (Yahoo! News) (11/28/11) Merck Pleads Guilty, Agrees to Pay $950 Million in Vioxx Case (Forbes) (11/28/11) GM to Offer Free Loaner Cars to Volt Owners During Safety Probe (Chicago Tribune) (11/28/11) Oklahoma Gets String of Mild Earthquakes (New York Times) (11/28/11) --

January 24, 2012

Copyright 2012© LRP Publications

                     

View the Original article